Short Interest in Rapid Micro Biosystems, Inc. (NASDAQ:RPID) Declines By 27.9%

Rapid Micro Biosystems, Inc. (NASDAQ:RPIDGet Free Report) was the recipient of a significant decrease in short interest in the month of March. As of March 31st, there was short interest totalling 57,900 shares, a decrease of 27.9% from the March 15th total of 80,300 shares. Based on an average daily trading volume, of 73,200 shares, the short-interest ratio is presently 0.8 days. Currently, 0.3% of the shares of the company are short sold.

Hedge Funds Weigh In On Rapid Micro Biosystems

A number of large investors have recently made changes to their positions in the company. American International Group Inc. increased its stake in shares of Rapid Micro Biosystems by 79.5% during the first quarter. American International Group Inc. now owns 7,880 shares of the company’s stock worth $54,000 after purchasing an additional 3,491 shares during the period. Tower Research Capital LLC TRC increased its stake in shares of Rapid Micro Biosystems by 78.7% during the third quarter. Tower Research Capital LLC TRC now owns 17,363 shares of the company’s stock worth $56,000 after purchasing an additional 7,645 shares during the period. Rhumbline Advisers bought a new position in shares of Rapid Micro Biosystems during the first quarter worth approximately $72,000. Charles Schwab Investment Management Inc. increased its stake in shares of Rapid Micro Biosystems by 65.6% during the first quarter. Charles Schwab Investment Management Inc. now owns 35,478 shares of the company’s stock worth $241,000 after purchasing an additional 14,059 shares during the period. Finally, Goldman Sachs Group Inc. increased its stake in shares of Rapid Micro Biosystems by 72.9% during the second quarter. Goldman Sachs Group Inc. now owns 53,490 shares of the company’s stock worth $230,000 after purchasing an additional 22,545 shares during the period. Institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Trading Down 3.9 %

NASDAQ:RPID traded down $0.04 on Friday, hitting $0.95. The company’s stock had a trading volume of 118,540 shares, compared to its average volume of 32,032. The stock has a fifty day moving average of $0.98 and a two-hundred day moving average of $0.99. The firm has a market capitalization of $40.33 million, a P/E ratio of -0.78 and a beta of 1.25. Rapid Micro Biosystems has a one year low of $0.74 and a one year high of $1.19.

Rapid Micro Biosystems (NASDAQ:RPIDGet Free Report) last released its quarterly earnings data on Friday, March 1st. The company reported ($0.26) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.05. The firm had revenue of $6.34 million for the quarter, compared to analyst estimates of $6.30 million. Rapid Micro Biosystems had a negative return on equity of 39.02% and a negative net margin of 232.99%. During the same quarter in the prior year, the company earned ($0.39) earnings per share. As a group, sell-side analysts anticipate that Rapid Micro Biosystems will post -1.09 EPS for the current year.

About Rapid Micro Biosystems

(Get Free Report)

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.

Recommended Stories

Receive News & Ratings for Rapid Micro Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rapid Micro Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.